Europe Point of Care Diagnostics Market Trends, Size, Segment and Growth by Forecast to 2030

Market Overview and Dynamics

The Europe point of care (POC) diagnostics market is projected to grow significantly, rising from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028, at a compound annual growth rate (CAGR) of 12.3% during the forecast period. This growth is driven by several key factors that are reshaping the landscape of diagnostic healthcare in the region.

A major contributor to this expansion is the increasing adoption of home-based POC devices, fueled by rising awareness and consumer demand for convenient, rapid diagnostic solutions. These devices enable patients to perform critical tests in the comfort of their homes, eliminating the need for frequent clinic visits. Clinicians are also recognizing POC testing as essential for early detection of life-threatening conditions, thanks to its ability to deliver real-time results.

đź“šDownload Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00023727

Moreover, the integration of smartphones with diagnostic technologies is accelerating market adoption. Consumers increasingly use smartphones equipped with health-monitoring apps for imaging, sensing, and diagnostics. Traditional home-use devices like glucose meters are now being repurposed for a broader range of clinical applications, including immunoassays, molecular diagnostics, and enzymatic assays, highlighting the market’s innovation potential.

The aging population across Europe is another pivotal driver. As the geriatric demographic grows, so does the demand for regular health checkups and diagnostics. Common conditions among older adults—such as cardiovascular diseases, diabetes, bone and joint disorders, and various cancers—necessitate frequent and accessible testing. This demographic shift is significantly boosting the demand for POC diagnostics across the region.

Overall, the Europe POC diagnostics market is on a strong upward trajectory, supported by technological advancements, demographic changes, and shifting healthcare preferences that emphasize decentralized and patient-centric care.

Market Introduction

Europe is the second-largest market for point-of-care diagnostics, with key contributions from the UK, Germany, France, Italy, Spain, and other European countries. The market’s growth is driven by increasing demand for advanced diagnostic solutions, a rising prevalence of infectious and chronic diseases, and growing investments in research and development. Additionally, the presence of a well-established manufacturing infrastructure for diagnostic products supports the expansion of the point-of-care diagnostics market in the region.

Germany currently leads the market, supported by government initiatives aimed at improving healthcare outcomes. For example, in November 2017, Lilly Germany launched the Diabetes Work initiative to raise awareness about diabetes—an effort expected to increase the adoption of diagnostic kits. Furthermore, in September 2018, the German government approved the marketing and sale of over-the-counter (OTC) HIV home testing kits, further facilitating market growth.

The COVID-19 pandemic significantly impacted Europe, particularly in countries like France, Spain, Italy, Germany, and the UK, which reported high infection and mortality rates. The World Health Organization (WHO) declared COVID-19 a Public Health Emergency of International Concern under the International Health Regulations. The surge in infections accelerated the demand for rapid and advanced diagnostic solutions, creating favorable conditions for the widespread adoption of point-of-care diagnostic kits across the region.

Despite the challenges posed by the pandemic, increased investments and proactive measures by industry players have continued to propel market growth. In 2020, the European Medicines Agency (EMA) approved 97 medicines for marketing authorization, including 39 novel drugs. Companies also launched innovative COVID-19 testing solutions to meet demand. For instance, Eurofins introduced COVID-19 PCR tests with at-home self-sampling in October 2020. Around the same time, Siemens Healthineers launched the CLINITEST rapid antigen test, which delivers results in 15 minutes. In April 2021, QIAGEN announced the launch of its Prep&Amp technology to accelerate COVID-19 testing. The kit received CE approval for distribution in Europe and was submitted for Emergency Use Authorization (EUA) in the U.S.

Europe Point of Care Diagnostics Strategic Insights

Strategic insights for the Europe Point of Care Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Market leaders and key company profiles
  Abbott

  BD

  bioMerieux SA

  BIO-RAD LABORATORIES INC.

  Danaher

  F. HOFFMANN-LA ROCHE LTD.

  Johnson and Johnson Services, Inc.

  Nova Biomedical

  Polymer Technology Systems, Inc. (PTS)

  Siemens AG

Europe Point of Care Diagnostics Regional Insights

The geographic scope of the Europe Point of Care Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Key Market Segments

In 2020, glucose monitoring products dominated the Europe point-of-care diagnostics market by product type. Based on prescription mode, the prescription-based testing segment held the largest market share. Regarding end users, professional diagnostic centers accounted for the highest share of the market.

Major Sources and Companies Featured

Key primary and secondary sources used in the preparation of this report include company websites, annual and financial reports, government publications, and statistical databases. Leading companies profiled in the report include:

  • Abbott
  • BD
  • bioMĂ©rieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • Polymer Technology Systems, Inc. (PTS)
  • Siemens AG

Reasons to Purchase This Report

  • Gain a comprehensive understanding of the Europe point-of-care diagnostics market and identify high-return segments
  • Stay competitive by monitoring the dynamic market landscape
  • Strategically plan mergers, acquisitions, and partnerships by targeting promising segments
  • Make informed business decisions backed by in-depth analysis of market segment performance
  • Access detailed revenue forecasts for key segments from 2021 to 2028 across the European region

Can you see this our reports

Europe Animal Feed Additives Market – https://postyourarticle.com/europe-animal-feed-additives-market-trends-size-segment-and-growth-by-forecast-to-2030-3/

North America Image Analysis Software Market – https://businessmarketins02.blogspot.com/2025/05/north-america-image-analysis-software.html

North America Narcolepsy Market – https://findit.com/uwttwdjttmkjdpa/RightNow/northamerica-narcolepsy-markettrends-sizes/9e853238-2ac0-4067-944a-508f5272604a

North America Ice Cream Market – https://www.linkedin.com/feed/update/urn:li:activity:7327663962341208064?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFopQoABFrzJW381cglVQWiY-cw6zAXFC7M

North America Secure Logistics Market – https://github.com/businessmarketinsights985/business-market-insights/issues/44

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & DĂ©fense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights

Akshay patil
Author: Akshay patil